Gene · 3853
Papers1,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crystal Structures Reveal Hidden Domain Mechanics in Protein Kinase A (PKA). | Biology (Basel) | 2023 | 37997969 | PubTator, text mining | PubMed |
| The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. | Mol Cancer | 2023 | 37980528 | PubTator, text mining | PubMed |
| Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma. | BMC Cancer | 2023 | 37974107 | PubTator, text mining | PubMed |
| COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. | BMC Gastroenterol | 2023 | 37974070 | PubTator, text mining | PubMed |
| Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS. | PLoS One | 2023 | 37967076 | PubTator, text mining | PubMed |
| Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis. | Cell Rep | 2023 | 37967009 | PubTator, text mining | PubMed |
| Marker-based CRISPR screening reveals a MED12-p63 interaction that activates basal identity in pancreatic ductal adenocarcinoma. | bioRxiv | 2023 | 37961243 | PubTator, text mining | PubMed |
| KRT17 from skin cells with high glucose stimulation promotes keratinocytes proliferation and migration. | Front Endocrinol (Lausanne) | 2023 | 37929023 | PubTator, text mining | PubMed |
| AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma. | Front Mol Biosci | 2023 | 37908231 | PubTator, text mining | PubMed |
| Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells. | Anal Bioanal Chem | 2023 | 37906289 | PubTator, text mining | PubMed |
| STS and PUDP Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review. | Genes (Basel) | 2023 | 37895274 | PubTator, text mining | PubMed |
| Ethnic, Botanic, Phytochemistry and Pharmacology of the Acorus L. Genus: A Review. | Molecules | 2023 | 37894595 | PubTator, text mining | PubMed |
| Discovering individual-specific gait signatures from data-driven models of neuromechanical dynamics. | PLoS Comput Biol | 2023 | 37889927 | PubTator, text mining | PubMed |
| Metabolic and senescence characteristics associated with the immune microenvironment in non-small cell lung cancer: insights from single-cell RNA sequencing. | Aging (Albany NY) | 2023 | 37889543 | PubTator, text mining | PubMed |
| Molecular detection of per- and polyfluoroalkyl substances in water using time-of-flight secondary ion mass spectrometry. | Front Chem | 2023 | 37867995 | PubTator, text mining | PubMed |
| In vitro vascularized immunocompetent patient-derived model to test cancer therapies. | iScience | 2023 | 37860774 | PubTator, text mining | PubMed |
| Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions. | ACS Infect Dis | 2023 | 37850869 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature. | Sci Rep | 2023 | 37845218 | PubTator, text mining | PubMed |
| Anti-inflammatory and Antiphytopathogenic Fungal Activity of 2,3-seco-Tirucallane Triterpenoids Meliadubins A and B from Melia dubia Cav. Barks with ChemGPS-NP and In Silico Prediction. | ACS Omega | 2023 | 37841162 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3853/papers?page=9